Blog

8 Dec 2023

Bluebird bio nets 3rd gene therapy approval since company split

8 Dec 2023

First-ever CRISPR drug, made by two Boston companies, is approved in the US

8 Dec 2023

Form D Friday: Rapid7’s vendor, new insurance startup get capital

8 Dec 2023

BPDA board OKs new Holocaust museum on edge of Boston Common

8 Dec 2023

Five things: More pickleball in Boston, Gillette’s Southie property, and t...

8 Dec 2023

Investors react to Boston VC firm’s collapse: ‘Omen’ or ‘...

8 Dec 2023

Cannabis equity fund money will finally go to businesses after months of red tap...

8 Dec 2023

How Covid’s ‘reset’ led to long-term growth for marlo marketin...

8 Dec 2023

For local banks, acquisitions have been the main way to add branches

7 Dec 2023

Boston Pickle Club to open first pickleball venue in Hyde Park

7 Dec 2023

Gillette to pursue mix of commercial, housing, parks at South Boston site

7 Dec 2023

MIT ordered to produce internal report into research misconduct at OpenAg